691 results match your criteria Thyrotoxicosis Imaging


Scintigraphy evaluation of hyperthyroidism and its correlation with clinical and biochemical profiles.

BMC Res Notes 2020 Jul 6;13(1):324. Epub 2020 Jul 6.

Taif University School of Medicine, Taif, Saudi Arabia.

Objective: Hyperthyroidism is the excessive synthesis of thyroid hormones. Thyroid uptake scans and ultrasonography provide an accurate diagnosis of hyperthyroidism, especially when thyroid receptor antibody (TRAb) measurement is not readily available. This study explored the prevalence of various hyperthyroidism causes using retrospective scintigraphy results and evaluated their relationship with clinical, biochemical, and sonographic imaging parameters from patients who underwent Tc-pertechnetate thyroid scans between 2016 and 2019 in Taif, Saudi Arabia, where literature is insufficient. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13104-020-05164-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339512PMC

Fluctuations in Moyamoya Vasculopathy Associated with Basedow Disease Depending on Thyroid Hormone Status.

Case Rep Neurol 2020 May-Aug;12(2):140-147. Epub 2020 May 20.

Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

A 31-year-old woman presented with sudden onset of weakness in her left upper limb. Magnetic resonance imaging revealed acute cerebral infarctions in the right frontal and parietal lobes. Magnetic resonance angiography showed stenosis in the proximal portions of the bilateral middle cerebral arteries and terminal portions of the bilateral internal carotid arteries. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000502571DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315203PMC

Approach to the Patient With Thyrotoxicosis Using Telemedicine.

J Clin Endocrinol Metab 2020 08;105(8)

Division of Diabetes, Endocrinology, and Metabolism, Vanderbilt University Medical Center, Nashville, Tennessee.

Context: The potential for endocrine care via telemedicine has been recognized since the early 2000s when clinical outcome data demonstrated improvements in glycemic control with telemedicine. The widespread use of telemedicine during the COVID-19 pandemic has pushed telemedicine beyond diabetes care and into clinical areas with a paucity of published data. The evaluation and treatment of thyrotoxicosis heavily relies on laboratory assessment and imaging with physical exam playing a role to help differentiate the etiology and assess the severity of thyrotoxicosis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/clinem/dgaa373DOI Listing

AMIODARONE-INDUCED THYROTOXICOSIS AFTER TOTAL THYROIDECTOMY FOR METASTATIC FOLLICULAR THYROID CANCER.

AACE Clin Case Rep 2020 Mar-Apr;6(2):e70-e72. Epub 2019 Dec 20.

Objective: To describe the case of a man who developed amiodarone-induced thyrotoxicosis (AIT) after a total thyroidectomy for metastatic follicular thyroid cancer because of the effect of the drug on metastasis. To the best of our knowledge this is the first reported case of this condition.

Methods: We completed a retrospective review of medical records and laboratory results including thyroid function tests as well as imaging reports including plain radiographs, positron emission tomographs, computed tomographs, and histology reports. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4158/ACCR-2019-0515DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282155PMC
December 2019

Hyperthyroidism.

Ann Intern Med 2020 Apr;172(7):ITC49-ITC64

University of Colorado School of Medicine, Denver, Colorado (M.T.M.).

Thyrotoxicosis is a general term for excess circulating and tissue thyroid hormone levels, whereas hyperthyroidism specifically denotes disorders involving a hyperactive thyroid gland (Graves disease, toxic multinodular goiter, toxic adenoma). Diagnosis and determination of the cause rely on clinical evaluation, laboratory tests, and imaging studies. Hyperthyroidism is treated with antithyroid drugs, radioactive iodine ablation, or thyroidectomy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7326/AITC202004070DOI Listing

Acute spontaneous suppurative thyroiditis caused by Eikenella corrodens presented with thyrotoxicosis.

Einstein (Sao Paulo) 2020 23;18:eRC5273. Epub 2020 Mar 23.

Ankara Yildirim Beyazit University, Faculty of Medicine, Ankara, Turkey.

Acute suppurative thyroiditis is a very rare and life-threatening endocrine emergency. Thyrotoxicosis is a rare condition accompanying acute suppurative thyroiditis. While the majority of the cases in the literature are caused by different reasons, spontaneous development is very rare. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.31744/einstein_journal/2020RC5273DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087456PMC

Hyperthyroidism.

Gland Surg 2020 Feb;9(1):124-135

Division of Endocrine Surgery, Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.

Hyperthyroidism is a condition where the thyroid gland produces and secretes inappropriately high amounts of thyroid hormone which can lead to thyrotoxicosis. The prevalence of hyperthyroidism in the United States is approximately 1.2%. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/gs.2019.11.01DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082267PMC
February 2020

Pure T3 thyrotoxicosis from a Struma Ovarii characterised by a paradoxical rise in thyroxine on treatment.

Endocrinol Diabetes Metab Case Rep 2020 Mar 13;2020. Epub 2020 Mar 13.

Department of Endocrinology, Croydon University Hospital, London, UK.

Summary: A 33-year-old female presented with a right 11.6 cm ovarian cyst. Routine pre-operative thyroid function tests showed thyroid stimulating hormone (TSH) of less than 0. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/EDM-19-0097DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077589PMC

Infiltration of the thyroid gland by non-thyroid malignancy: A literature review reveals this to be an unusual cause of hyperthyroidism.

J Clin Transl Endocrinol 2020 Jun 19;20:100221. Epub 2020 Feb 19.

Division of Endocrinology, Georgetown University, Washington, DC, USA.

Background: Non-thyroid malignancies that metastasize to the thyroid gland are relatively rare. At one end of the spectrum they may only be identified at the time of autopsy. At the other extreme, they may be identified during the evaluation of a progressive malignancy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcte.2020.100221DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052397PMC

A systematic review of the incidence of thyroid carcinoma in patients undergoing thyroidectomy for thyrotoxicosis.

Clin Otolaryngol 2020 Jul 20;45(4):538-544. Epub 2020 Apr 20.

ENT Consultant, Surrey & Sussex NHS Trust, Redhill, UK.

Introduction: Hyperthyroidism (HT) has been associated with no insignificant rates of thyroid malignancy. There are no current specific guidelines that suggest routine preoperative imaging for thyroid nodules in patients with Grave's disease. We therefore performed a systematic review assessing rates of thyroid malignancy in patients undergoing surgery for different causes of HT: Grave's disease (GD), toxic adenoma (TA) and toxic multinodular goitre (TMNG). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/coa.13527DOI Listing

Laser Ablation Versus Radiofrequency Ablation for Benign Non-Functioning Thyroid Nodules: Six-Month Results of a Randomized, Parallel, Open-Label, Trial (LARA Trial).

Thyroid 2020 Jun 17;30(6):847-856. Epub 2020 Mar 17.

Unit of Endocrinology and Diabetes, Campus Bio-Medico University, Rome, Italy.

No direct prospective studies comparing laser ablation (LA) and radiofrequency ablation (RFA) for debulking benign non-functioning thyroid nodules (BNTNs) exist. We aimed at comparing the efficacy and safety of both techniques in patients with solid or predominantly solid BNTN. This six-month, single-use, randomized, open-label, parallel trial compared the following primary endpoints between the RFA and LA groups six months after treatment: (i) nodule volume reduction expressed as a percentage of nodule volume at baseline; (ii) proportion of nodules with more than 50% reduction (successful rate). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/thy.2019.0660DOI Listing

PANCYTOPENIA AND LYMPHOID ORGAN HYPERPLASIA IN A PATIENT WITH GRAVES DISEASE: RESPONSE TO ANTITHYROID DRUG THERAPY.

AACE Clin Case Rep 2019 Nov-Dec;5(6):e388-e392. Epub 2019 Aug 28.

Objective: In rare instances, cytopenias manifest as a complication of thyrotoxicosis. Here, we report a case of Graves disease (GD) thyrotoxicosis presenting as pancytopenia that resolved with antithyroid therapy.

Methods: A 35-year-old male presented with fever and chills following an outpatient colonoscopy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4158/ACCR-2019-0170DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873849PMC

COINCIDENT SUPPURATIVE THYROIDITIS AND GRAVES DISEASE IN A PATIENT WITH INFECTED BRANCHIAL CLEFT CYST.

AACE Clin Case Rep 2019 Nov-Dec;5(6):e365-e368. Epub 2019 Aug 14.

Objective: Acute suppurative thyroiditis (AST) is frequently caused by anatomic abnormalities, including branchial cleft cysts. Patients with AST are typically euthyroid, but thyrotoxicosis may occur. Thyroid antibodies are usually not present in AST. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4158/ACCR-2019-0236DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873837PMC

GLUCOSE CHANGES IN A PATIENT WITH INSULIN AUTOIMMUNE SYNDROME DEMONSTRATED BY CONTINUOUS GLUCOSE MONITORING.

AACE Clin Case Rep 2019 Jan-Feb;5(1):e35-e39. Epub 2019 Jan 30.

Objective: Insulin autoimmune syndrome (IAS) is an unusual cause of hypoglycemia in individuals without underlying diseases. Continuous glucose monitoring (CGM) has rarely been applied for IAS. We present a case of IAS with available 6-day CGM data. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4158/ACCR-2018-0258DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6876980PMC
January 2019

Diagnostic testing for Graves' or non-Graves' hyperthyroidism: A comparison of two thyrotropin receptor antibody immunoassays with thyroid scintigraphy and ultrasonography.

Clin Endocrinol (Oxf) 2020 02 5;92(2):169-178. Epub 2019 Dec 5.

Clinic for Nuclear Medicine and Competence Thyroid Centre, Imaging Institute of Southern Switzerland, Bellinzona, Switzerland.

Objective: Graves' disease (GD) is the most common cause of hyperthyroidism. In many cases, when the aetiological diagnosis of GD is not evident based on the clinical evaluation and thyroid function testing, it may become challenging to distinguish Graves' hyperthyroidism from other forms of thyrotoxicosis. The current study was primarly carried out to compare the diagnostic effectiveness of two TSH receptor antibody immunoassays (IMAs), ultrasonography and thyroid scintigraphy in hyperthyroidism scenario. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cen.14130DOI Listing
February 2020
4 Reads

Thyroid Storm with Multiorgan Failure Treated with Plasmapheresis.

Case Rep Endocrinol 2019 9;2019:2475843. Epub 2019 Oct 9.

Division of Endocrinology, Diabetes, and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.

Background: Thyroid storm is a severe manifestation of thyrotoxicosis and can present with multiorgan failure. First line treatment of thyroid storm is directed towards decreasing thyroid hormone production and peripheral conversion of T4 to T3, and treating adrenergic symptoms. When medical therapy fails, plasmapheresis is an alternative treatment option. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2019/2475843DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811794PMC
October 2019
1 Read

Clinical heterogeneity of hypophysitis secondary to PD-1/PD-L1 blockade: insights from four cases.

Endocrinol Diabetes Metab Case Rep 2019 Oct 12;2019. Epub 2019 Oct 12.

Endocrinology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Summary: Programmed cell death protein 1/programmed cell death protein ligand 1 (PD-1/PD-L1) and cytotoxic T-lymphocyte antigen 4/B7 (CTLA-4/B7) pathways are key regulators in T-cell activation and tolerance. Nivolumab, pembrolizumab (PD-1 inhibitors), atezolizumab (PD-L1 inhibitor) and ipilimumab (CTLA-4 inhibitor) are monoclonal antibodies approved for treatment of several advanced cancers. Immune checkpoint inhibitors (ICIs)-related hypophysitis is described more frequently in patients treated with anti-CTLA-4; however, recent studies reported an increasing prevalence of anti-PD-1/PD-L1-induced hypophysitis which also exhibits slightly different clinical features. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/EDM-19-0102DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790893PMC
October 2019

Hypercalcaemia in a patient with paranoid schizophrenia - a case report.

Pol Merkur Lekarski 2019 Sep;47(279):103-105

Department of Pathophysiology and Endocrinology, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia, Katowice, Poland.

Hypercalcaemia is associated with a number of symptoms that appear in of various parts of body systems. Renal dysfunction or cardiovascular abnormalities present only a part of the multidirectional action of the disturbed calcium balance. It is important for every diagnosis to know the cause of this condition and the mechanism that is responsible in a given situation for the distribution of calcium ions. Read More

View Article

Download full-text PDF

Source
September 2019
6 Reads

R-CHOP-Associated Graves' Hyperthyroidism.

Case Rep Oncol 2019 May-Aug;12(2):581-588. Epub 2019 Jul 24.

Department of Endocrinology, Walter Reed National Military Medical Center, Bethesda, Maryland, USA.

Radiation-induced thyroid dysfunction following oncologic treatment is not uncommon, however limited literature data has been found on patients that underwent chemotherapy only. A change in thyrometabolic autoimmune status is also a rare entity. We present a case of newly diagnosed Graves' thyrotoxicosis following a successful R-CHOP (Rituximab, Cyclophosphamide, Doxorubicine, Vincristine and Prednisone) treatment in a patient with concurrent abdominal and thyroid diffuse large B-cell lymphoma (DLBCL). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000501714DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738228PMC
July 2019
1 Read

Comparison between peak systolic velocity of the inferior thyroid artery and technetium-99m pertechnetate thyroid uptake in differentiating Graves' disease from thyroiditis.

Arch Endocrinol Metab 2019 2;63(5):495-500. Epub 2019 Sep 2.

Department of Endocrinology, SKIMS, Srinagar, India.

Objectives: The differentiation between the various etiologies of thyrotoxicosis, including those with hyperthyroidism (especially Graves' disease [GD], the most common cause of hyperthyroidism) and without hyperthyroidism (like thyroiditis), is an important step in planning specific therapy. Technetium-99m (99mTc) pertechnetate thyroid scanning is the gold standard in differentiating GD from thyroiditis. However, this technique has limited availability, is contraindicated in pregnancy and lactation, and is not helpful in cases with history of recent exposure to excess iodine. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.20945/2359-3997000000165DOI Listing
October 2019
1 Read

Hypercalcaemia, adrenal insufficiency and bilateral adrenal histoplasmosis in a middle-aged man: a diagnostic dilemma.

BMJ Case Rep 2019 Aug 28;12(8). Epub 2019 Aug 28.

Endocrinology, All India Institute of Medical Sciences, New Delhi, India.

A 45-year-old man presented with a 3-month history of involuntary weight loss, anorexia, postural dizziness and intermittent fever. On investigation, he was found to have parathyroid hormone (PTH)-independent hypercalcaemia, with negative workup for 25-hydroxyvitamin D or 1,25-dihydroxyvitamin D excess, thyrotoxicosis, multiple myeloma and bony metastases. On further evaluation, he was detected to have primary hypoadrenalism with bilateral adrenal enlargement, secondary to adrenal histoplasmosis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bcr-2019-231142DOI Listing
August 2019
3 Reads

EANM practice guideline/SNMMI procedure standard for RAIU and thyroid scintigraphy.

Eur J Nucl Med Mol Imaging 2019 Nov 7;46(12):2514-2525. Epub 2019 Aug 7.

Division of Nuclear Medicine, Department of Radiology, David Grant Medical Center, Vacaville, CA, USA.

Introduction: Scintigraphic evaluation of the thyroid gland enables determination of the iodine-123 iodide or the Tc-pertechnetate uptake and distribution and remains the most accurate method for the diagnosis and quantification of thyroid autonomy and the detection of ectopic thyroid tissue. In addition, thyroid scintigraphy and radioiodine uptake test are useful to discriminate hyperthyroidism from destructive thyrotoxicosis and iodine-induced hyperthyroidism, respectively.

Methods: Several radiopharmaceuticals are available to help in differentiating benign from malignant cytologically indeterminate thyroid nodules and for supporting clinical decision-making. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-019-04472-8DOI Listing
November 2019
3 Reads

A Comparison of the Clinical Presentation of Ovarian Hyperstimulation Syndrome in a Partial Molar Pregnancy Case Versus a Fertility Treatment Case.

Cureus 2019 May 22;11(5):e4718. Epub 2019 May 22.

Radiology and Imaging, Medical College of Georgia at Augusta University Medical Center, Augusta, USA.

Ovarian hyperstimulation syndrome (OHSS) is ovarian enlargement secondary to hormones overstimulating ovarian growth. It can be associated with a spectrum of other clinical findings, including ascites, hemoconcentration, hypercoagulability, and electrolyte imbalances. OHSS most commonly occurs as a complication of treatment with in vitro fertilization medications, such as human chorionic gonadotropin (hCG) or gonadotropin-releasing hormone agonists. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7759/cureus.4718DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6650176PMC
May 2019
2 Reads

Painless Thyroiditis with Thyrotropin Receptor-blocking and Receptor-stimulating Autoantibodies.

Authors:
Keiichi Kamijo

Intern Med 2019 Nov 10;58(21):3121-3123. Epub 2019 Jul 10.

Department of Internal Medicine, Kamijo Thyroid Clinic, Japan.

We herein report a rare case of a 41-year-old woman with painless thyroiditis who was positive for thyrotropin (TSH) receptor-blocking (TBAbs) and receptor-stimulating autoantibodies (TSAbs) in the thyrotoxic phase. Her serum thyroid hormone levels were high, and TSH was undetectable. The low uptake of Tc led to the diagnosis of painless thyroiditis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2169/internalmedicine.3212-19DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6875451PMC
November 2019

A Case of Marine-Lenhart Syndrome with Predominance of Plummer Disease.

J UOEH 2019 ;41(2):165-170

First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan.

A 74-year-old woman with a left neck mass and thyrotoxicosis was referred to our hospital, and was later diagnosed with Marine-Lenhart syndrome based on positivity for thyroid autoantibodies, ultrasonographically evident left lobe thyroid nodule with increased blood flow, and scintigraphically identified not only increased tumor-like accumulation but also diffused uptake. Disease control was difficult despite administration of antithyroid drugs, so subtotal thyroidectomy was performed. No hyperplastic changes or histopathological findings characteristic of Graves disease were evident on histopathology, so Plummer disease was considered to be dominant. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7888/juoeh.41.165DOI Listing
December 2019
2 Reads

[Differential diagnosis between autoimmune thyrotoxicosis and thyroid hormone resistance syndrome: clinical case report].

Probl Endokrinol (Mosk) 2019 06 30;65(2):95-100. Epub 2019 Jun 30.

Endocrinology Research Centre.

We report a case of 50-year-old woman with thyroid hormone resistance syndrome. For 20 years this patient have been treated for autoimmune thyrotoxicosis: she underwent thyroid surgery and then was on thyroid-blocking therapy. Repeated laboratory tests demonstrated elevated serum thyroid hormones concentrations and elevated TSH concentration. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14341/probl9747DOI Listing
June 2019
2 Reads

Multi-detector CT enterography in active inflammatory bowel disease: Image quality and diagnostic efficacy of a low-radiation high contrast protocol.

Clin Imaging 2019 Nov - Dec;58:27-33. Epub 2019 Jun 14.

Department of Advanced Biomedical Sciences - Section of Diagnostic Imaging, University "Federico II", Naples, Italy.

Purpose: To prospectively evaluate image quality and diagnostic efficacy of a low radiation-high contrast (LR-HC) CT Enterography (CTE) in active Inflammatory Bowel Disease (IBD).

Materials And Methods: Eighty-five (36M; 49F; 17-75 yrs) patients with active IBD underwent contrast-enhanced CTE and were stratified in two groups according to age (< or ≥45 yrs): Group A (N = 45; 32 ± 9 yrs; 58 ± 10 kg) and Group B (N = 40; 58 ± 10 yrs; 61 ± 13 kg). Each group received a different amount of radiation (Noise Index, NI) and non-ionic iodinated contrast media (LOCM) as follows: Group A (NI = 15; 2. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinimag.2019.06.007DOI Listing
February 2020
10 Reads

Coma in Thyroid Storm: Review of Aggregated English-Language Case Reports.

J Endocr Soc 2019 Jul 24;3(7):1261-1274. Epub 2019 Apr 24.

Division of Diabetes, Endocrinology & Metabolism, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.

Context: Coma is a serious manifestation of thyroid storm (TS) about which little is known.

Objective: To describe the features, duration, treatment response, and prognosis of coma in the setting of TS.

Design: Aggregate analysis of individual English-language case reports of coma in the setting of TS from 1935 to January 2019. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/js.2019-00076DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6570633PMC
July 2019
12 Reads

Mean peak systolic velocity of superior thyroid artery for the differential diagnosis of thyrotoxicosis: a diagnostic meta-analysis.

BMC Endocr Disord 2019 Jun 6;19(1):56. Epub 2019 Jun 6.

Department of Gastroenterology, The First Affiliated Hospital, Jinan University, Guangzhou, 510630, Guangdong, China.

Background: Thyrotoxicosis is often caused by destructive thyroiditis (DT) or Graves' disease (GD), and a prompt and accurate differential diagnosis for thyrotoxicosis is needed as management strategy differs. A meta-analysis of published literature was performed to evaluate the diagnostic accuracy for differentiating GD from DT patients by the measurement of mean peak systolic velocity of superior thyroid artery (STA-PSV) using ultrasonography.

Methods: The databases of Embase, Pubmed, Cochrane, Web of Science, Wanfang, and CNKI were retrieved without time limit to identify eligible studies. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12902-019-0388-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554950PMC
June 2019
4 Reads

A Case of Dynamic Evolution of Thyrotoxicosis on Follow-up.

J Coll Physicians Surg Pak 2019 Jun;29(6):S5-S7

Department of Endocrinology, Yangzhou University Affiliated Jiangdu People's Hospital of Yangzhou City, China.

A 55-year female patient presented with subacute thyroiditis (SAT) with a unique dynamic evolution, along with changes in the level of antithyroglobulin antibody, which has been rarely reported. Her thyrotoxicosis gradually worsened over the next three months. Severe hypothyroidism then rapidly developed and did not resolve. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.29271/jcpsp.2019.06.S5DOI Listing
June 2019
26 Reads

Pembrolizumab-Induced Thyroiditis.

Endocr Pathol 2019 Jun;30(2):163-167

Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, 3400 Spruce Street, Six Founders Pavilion, Philadelphia, PA, 19104-4283, USA.

Immune checkpoint inhibitors act to restore T cell-mediated antitumor immunity. By this nature, these cancer immunotherapy drugs are associated with various immune-related adverse events such as thyroid dysfunction. We describe a case of thyrotoxicosis secondary to a programmed cell death 1 (PD-1) immune checkpoint inhibitor, pembrolizumab. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12022-019-9579-2DOI Listing
June 2019
11 Reads

Non-contrast-enhanced magnetic resonance imaging for visualization and quantification of endovascular aortic prosthesis, their endoleaks and aneurysm sacs at 1.5 T.

Magn Reson Imaging 2019 07 7;60:164-172. Epub 2019 May 7.

Department of Radiology and Neuroradiology, University Medical Center Schleswig-Holstein (UKSH), Kiel University, Kiel, Germany.

Purpose: After an endovascular aortic aneurysm repair (EVAR), a follow-up at 1, 6 and every 12 months is recommended for remainder of the patient's life. The diagnostic standard methods for diagnosing endoleaks and visualization of aneurysms in EVAR-patients are: invasive digital subtraction angiography (DSA), contrast enhanced (CE) computed tomographic angiography (CE-CTA), and magnetic resonance angiography (CE-MRA). These techniques, however, require the use of iodine- or gadolinium-based contrast agents with rare, but possibly life threatening side effects such as renal impairment, thyrotoxicosis and allergic reactions, nephrogenic systemic fibrosis, and cerebral gadolinium deposition. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mri.2019.05.012DOI Listing
July 2019
9 Reads

DIAGNOSIS OF ENDOCRINE DISEASE: Evaluation of bone fragility in endocrine disorders.

Eur J Endocrinol 2019 Apr 1. Epub 2019 Apr 1.

I Chiodini, Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.

An underlying disease affecting bone health is present in up to 40% and 60% of osteoporotic post-menopausal women and men respectively. Among the disorders leading to a secondary form of osteoporosis, the endocrine diseases are highly represented. A frequent finding in patients affected with an endocrine-related forms of bone disease is that the skeletal fragility is partially independent of the bone density, since the fracture risk in these patients is related more to a reduction of bone quality than to a decrease of bone mass. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/EJE-18-0991DOI Listing
April 2019
9 Reads

Thyroid detectives: on the trail of Munchausen's syndrome.

BMJ Case Rep 2019 Apr 29;12(4). Epub 2019 Apr 29.

Endocrinology and Metabolism, IPGME&R and SSKM Hospital, Kolkata, West Bengal, India.

Thyrotoxicosis factitia, a disorder frequently seen in young or middle-aged women with psychological disorders, most commonly results from surreptitious ingestion of excess thyroid hormones. In most patients, diagnosis is relatively straightforward and depends on the demonstration of biochemical thyrotoxicosis, suppressed endogenous thyroid function and absence of clinical features of underlying thyroid disease. However, at times, confounding factors can make the diagnosis particularly challenging and necessitate the investigating physician to don the detective's cap to get to the root of the problem. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bcr-2018-226087DOI Listing
April 2019
70 Reads

Thyrotoxicosis with concomitant thyroid cancer.

Endocr Relat Cancer 2019 07;26(7):R395-R413

Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, People's Republic of China.

Thyrotoxicosis with concomitant thyroid cancer is rare and poorly recognized, which may result in delayed diagnosis, inappropriate treatment and even poor prognosis. To provide a comprehensive guidance for clinicians, the etiology, pathogenesis, diagnosis and treatment of this challenging setting were systematically reviewed. According to literatures available, the etiologies of thyrotoxicosis with concomitant thyroid cancer were categorized into Graves' disease with concurrent differentiated thyroid cancer (DTC) or medullary thyroid cancer, Marine-Lenhart Syndrome with coexisting DTC, Plummer's disease with concomitant DTC, amiodarone-induced thyrotoxicosis with concomitant DTC, central hyperthyroidism with coexisting DTC, hyperfunctioning metastases of DTC and others. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-19-0129DOI Listing
July 2019
4 Reads

Autoimmune thyroid disease following treatment with alemtuzumab for multiple sclerosis.

Int J Immunopathol Pharmacol 2019 Jan-Dec;33:2058738419843690

Department of Clinical and Experimental Medicine, University of Catania, Policlinico 'G. Rodolico', Catania, Italy.

Alemtuzumab, an anti-CD52 monoclonal antibody, is effective in the treatment of relapsing-remitting multiple sclerosis (RRMS). Common adverse effects include the development of autoimmune diseases, and Graves' disease is one of the most frequent presentations. We report here a case of alemtuzumab-induced thyroid disease in a female patient who showed a phase of thyrotoxicosis with positive anti-thyroglobulin (anti-Tg) and anti-thyroid peroxidase (TPO) antibodies, but a negative TSH receptor antibody, spontaneously followed by hypothyroidism. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2058738419843690DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458661PMC
July 2019
5 Reads

Thyroid hormone resistance and the value of genetics: Three case reports.

Medicine (Baltimore) 2019 Mar;98(9):e14675

Department of Endocrinology, Xiangya Hospital, Changsha, Central South University.

Rational: Thyroid hormone resistance (RTH) is a rare disease that is characterised by a lowered sensitivity of the target organs to thyroid hormone. Herein, we present 3 cases of confirmed RTH, with the support of clinical lab results and/or gene sequencing at diagnosis.

Patient Concerns: The 3 included patients were found to have elevated levels of free T3 (FT3), free T4 (FT4), and non-supressed levels of thyroid stimulating hormone (TSH). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000014675DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831408PMC
March 2019
8 Reads

A case report of 131I therapy for Graves' disease patient with hemiagenesis.

Medicine (Baltimore) 2019 Feb;98(8):e14606

Department of Nuclear Medicine, Third Central Hospital of Tianjin, Tianjin Institute of Hepatobiliary Disease, Tianjin Key Laboratory of Artificial Cell, Artificial Cell Engineering Technology Research Center of Public Health Ministry.

Rationale: Thyroid hemiagenesis is a rare congenital dysplasia, whereas a variety of pathological changes may occur in residual thyroid lobe. The most frequently described pathology in residual thyroid lobe is Graves' hyperthyroidism. Although I therapy has been generally recommended as the preferred treatment for Graves' disease (GD), subjects relating to hemiagenesis are very limited, especially in China. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000014606DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408000PMC
February 2019
24 Reads

Thyroid dysfunction induced by nivolumab: searching for disease patterns and outcomes.

Endocrine 2019 06 25;64(3):605-613. Epub 2019 Feb 25.

Department of Endocrinology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.

Purpose: Nivolumab is a monoclonal antibody that blocks the activation of programmed death-1 receptor, promoting T-cell activation against cancer cells. Thyroid dysfunction (TD) is a common immune-related adverse event (irAE) induced by nivolumab. We report the prevalence, patterns and outcomes of nivolumab-induced TD among cancer patients in our center. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12020-019-01871-7
Publisher Site
http://dx.doi.org/10.1007/s12020-019-01871-7DOI Listing
June 2019
30 Reads

Hypercalcaemic Crisis Due to Primary Hyperparathyroidism: Report of Two Cases.

J Crit Care Med (Targu Mures) 2019 Jan 4;5(1):34-39. Epub 2019 Feb 4.

University of Medicine, Pharmacy, Sciences and Technology of Târgu Mureş, Romania.

Introduction: A hypercalcaemic crisis, also called para thyrotoxicosis, hyper parathyroid crisis or parathyroid storm, is a complication of primary hyperparathyroidism (PHPT) and an endocrinology emergency that can have dramatic or even fatal consequences if it is not recognised and treated in time.

Case Presentation: Two cases presented in the emergency department with critical hypercalcaemic symptoms and severe elevation of serum calcium and parathyroid hormone levels, consistent with a hypercalcaemic crisis. The first case, a 16-year-old female patient, had imaging data that highlighted a single right inferior parathyroid adenoma and a targeted surgical approach was used. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2478/jccm-2019-0004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369571PMC
January 2019
10 Reads

Remarkable Response of Pulmonary Metastases Rather Than Remnant Thyroid in 131I Therapy of Follicular Thyroid Cancer.

Clin Nucl Med 2019 Apr;44(4):327-329

From the Departments of Nuclear Medicine.

A 66-year-old man with follicular thyroid cancer after total thyroidectomy was referred for I therapy. Thyroid function tests before I administration exhibited severe thyrotoxicosis although the patient did not take levothyroxine after thyroidectomy. A 185 MBq I whole-body scintigraphy and SPECT/CT revealed multiple iodine-avid pulmonary metastases with the largest tumor diameter of 1. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0000000000002477DOI Listing
April 2019
9 Reads

Plurihormonal Pituitary Tumor of Pit-1 and SF-1 Lineages, with Synchronous Collision Corticotroph Tumor: a Possible Stem Cell Phenomenon.

Endocr Pathol 2019 Mar;30(1):74-80

Department of Pathology, Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada.

Thyrotropin (TSH)-secreting pituitary tumors are the rarest functioning pituitary tumors. Nonetheless, they are not infrequently plurihormonal, as they may express/secrete hormones made by other pituitary cells derived from the Pit-1 lineage such as growth hormone (GH), prolactin (PRL), and α-subunit (αSU). However, adrenocorticotropin (ACTH) or gonadotropin secretion by such a tumor is exceptional. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12022-018-9562-3DOI Listing
March 2019
10 Reads

A silent myocardial infarction with normal coronary arteries associated with Graves' disease.

Heart Lung 2019 Jul - Aug;48(4):347-350. Epub 2018 Nov 28.

Division of Endocrinology, Tongji Hospital, Huazhong University of Science & Technology, Jiefang Road 1095, Wuhan 430030, Hubei, PR China. Electronic address:

Acute myocardial infarction (AMI) is a scarce but fatal complication in Graves' disease (GD). Silent myocardial infarction (MI) associated with GD has never been reported. A 37-year-old male patient was admitted due to poorly controlled hyperthyroidism and persistent fever. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hrtlng.2018.11.003DOI Listing
March 2020
5 Reads

Diabetic Ketoacidosis Associated with Thyroxine (T₄) Toxicosis and Thyrotoxic Cardiomyopathy.

Medicina (Kaunas) 2018 Nov 26;54(6). Epub 2018 Nov 26.

Department of Internal Medicine, Hospital Regional Lambayeque, Chiclayo, Lambayeque 14012, Peru.

Thyrotoxicosis and diabetic ketoacidosis (DKA) both may present as endocrine emergencies and may have devastating consequences if not diagnosed and managed promptly and effectively. The combination of diabetes mellitus (DM) with thyrotoxicosis is well known, and one condition usually precedes the other. Furthermore, thyrotoxicosis is complicated by some degree of cardiomyopathy in at least 5% de patients; but the coexistence of DKA, thyroxin (T₄) toxicosis, and acute cardiomyopathy is extremely rare. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/medicina54060093DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306916PMC
November 2018
5 Reads

Thyroiditis and immune check point inhibitors: the post-marketing experience using the French National Pharmacovigilance database.

Fundam Clin Pharmacol 2019 Apr 14;33(2):241-249. Epub 2018 Nov 14.

Department of Clinical Pharmacology and Pharmacovigilance, University Hospital of Nancy, 29 avenue du Maréchal de Lattre de Tassigny, Nancy, 54035, France.

Immunotherapy with immune checkpoint inhibitors (ICIs) for cancer has become increasingly prescribed in recent years. Indeed, it is used to treat both solid and hematological malignancies due to their considerable potential in treating melanoma, non-small cell lung and other cancers. Immune-mediated related adverse endocrine toxicity, and especially thyroiditis, is seen as a growing problem needing specific screening and management. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/fcp.12423
Publisher Site
http://dx.doi.org/10.1111/fcp.12423DOI Listing
April 2019
9 Reads

Radiocontrast-Induced Thyroid Storm.

Am J Ther 2019 Sep/Oct;26(5):e644-e645

Department of Medicine, St. Vincent's Medical Center, Bridgeport, CT.

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00045391-900000000-9855
Publisher Site
http://dx.doi.org/10.1097/MJT.0000000000000844DOI Listing
February 2020
9 Reads

Prospective Echocardiographic Evaluation of the Right Ventricle and Pulmonary Arterial Pressure in Hyperthyroid Patients.

Heart Lung Circ 2019 Aug 12;28(8):1190-1196. Epub 2018 Sep 12.

Department of Internal Medicine, Botucatu Medical School, Sao Paulo State University - UNESP, Botucatu, Sao Paulo, Brazil. Electronic address:

Background: Pulmonary arterial hypertension (PAH) occurs in 35% to 65% of hyperthyroid patients. Despite this high frequency, only a few authors have examined the effects of hyperthyroidism treatment on PAH and the right ventricle. We evaluated the effects of hyperthyroidism and its reversal on cardiovascular structure and function using Doppler echocardiography. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hlc.2018.06.1055DOI Listing
August 2019
16 Reads

Diagnostic procedure in suspected Graves' disease.

Ann Endocrinol (Paris) 2018 Dec 18;79(6):608-617. Epub 2018 Aug 18.

Service d'endocrinologie, CHU de Rabat, Rabat, Morocco.

Diagnostic procedure in suspected Graves' disease has never been studied scientifically and actual practice seems quite variable, notably between countries. Recommendations are few and weak (expert opinion). This article presents the recommendations of an expert consensus meeting organized by the French Society of Endocrinology in 2016. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ando.2018.08.002DOI Listing
December 2018
6 Reads
0.664 Impact Factor

[An enlarged thymus associated with Graves' disease].

Ned Tijdschr Geneeskd 2018 Jul 20;162. Epub 2018 Jul 20.

Scheper Ziekenhuis, afd. Endocrinologie, Emmen.

Background: Thyrotoxicosis and orbitopathy are the best-known expressions of Graves' disease. There are also rarer and less-known phenomena, such as thymic hyperplasia. Identification of these is important in order to avoid potentially unnecessary invasive interventions. Read More

View Article

Download full-text PDF

Source
July 2018
7 Reads